| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8607561 | Seminars in Radiation Oncology | 2018 | 7 Pages |
Abstract
The standard radiotherapy treatment for prostate cancer is intensity-modulated radiotherapy (IMRT). An alternative option is proton beam therapy (PBT). PBT is a safe and effective treatment, but does it add value over IMRT? We explore this controversial question by examining the available dosimetric and clinical evidence.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Eric MD, Justin E. MD,